{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:38:10Z","timestamp":1781905090432,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","award":["220134\/Z\/20\/Z"],"award-info":[{"award-number":["220134\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["PGL19-2\/10025"],"award-info":[{"award-number":["PGL19-2\/10025"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS125255"],"award-info":[{"award-number":["R01 NS125255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013114","name":"Broad Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbc.2024.107560","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:07:12Z","timestamp":1720721232000},"page":"107560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modulation of prion protein expression through cryptic splice site manipulation"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-4489","authenticated-orcid":false,"given":"Juliana E.","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor L.","family":"Corridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Mortberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5394-7260","authenticated-orcid":false,"given":"Elston Neil","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1554-6594","authenticated-orcid":false,"given":"Nicola","family":"Whiffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Vallabh","family":"Minikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3824-2702","authenticated-orcid":false,"given":"Sonia M.","family":"Vallabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107560_bib1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107560_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03403528","article-title":"High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene","volume":"1","author":"B\u00fceler","year":"1994","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2024.107560_bib3","article-title":"Antisense oligonucleotides extend survival of prion-infected mice","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2024.107560_bib4","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","article-title":"Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints","volume":"48","author":"Minikel","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107560_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","article-title":"Towards a treatment for genetic prion disease: trials and biomarkers","volume":"19","author":"Vallabh","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2024.107560_bib6","doi-asserted-by":"crossref","first-page":"e156532","DOI":"10.1172\/jci.insight.156532","article-title":"Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS","volume":"7","author":"Mortberg","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2024.107560_bib7","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1093\/nar\/gkad371","article-title":"A\u00a0single-cell map of antisense oligonucleotide activity in the brain","volume":"51","author":"Mortberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107560_bib8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107560_bib9","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a Selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107560_bib10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41589-019-0384-5","article-title":"Structural basis of a small molecule targeting RNA for a specific splicing correction","volume":"15","author":"Campagne","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107560_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.107560_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00109-006-0137-2","article-title":"Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia","volume":"85","author":"Hims","year":"2007","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.jbc.2024.107560_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1203\/PDR.0b013e31822e1825","article-title":"Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia","volume":"70","author":"Axelrod","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jbc.2024.107560_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107560_bib15","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1038\/s41467-022-34419-x","article-title":"An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington\u2019s disease patient neurons","volume":"13","author":"Krach","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107560_bib16","article-title":"RNA splicing modulator induces peripheral neuropathy with increased neurofilament light chain levels via p53 signaling","author":"Krach","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2024.107560_bib17","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1073\/pnas.0810916106","article-title":"Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans","volume":"106","author":"Calvo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107560_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.15252\/embj.201592759","article-title":"Upstream ORFs are prevalent translational repressors in vertebrates","volume":"35","author":"Johnstone","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107560_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41467-021-21812-1","article-title":"Disrupting upstream translation in mRNAs is associated with human disease","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107560_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ajhg.2021.04.025","article-title":"Non-coding region variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms","volume":"108","author":"Wright","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2024.107560_bib21","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/s41467-019-10717-9","article-title":"Characterising the loss-of-function impact of 5\u2019 untranslated region variants in 15,708 individuals","volume":"11","author":"Whiffin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107560_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nbt.3589","article-title":"Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames","volume":"34","author":"Liang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2024.107560_bib23","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1073\/pnas.91.14.6418","article-title":"Structure and polymorphism of the mouse prion protein gene","volume":"91","author":"Westaway","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107560_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1101\/gad.8.8.959","article-title":"Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie","volume":"8","author":"Westaway","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2024.107560_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(96)01407-2","article-title":"A\u00a0novel hamster prion protein mRNA contains an extra exon: increased expression in scrapie","volume":"751","author":"Li","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.jbc.2024.107560_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1101\/gr.8.10.1022","article-title":"Complete genomic sequence and analysis of the prion protein gene region from three mammalian species","volume":"8","author":"Lee","year":"1998","journal-title":"Genome Res."},{"key":"10.1016\/j.jbc.2024.107560_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gr.231902.117","article-title":"Base-specific mutational intolerance near splice sites clarifies the role of nonessential splice nucleotides","volume":"28","author":"Zhang","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.jbc.2024.107560_bib28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.15252\/msb.20145136","article-title":"Quantitative analysis of mammalian translation initiation sites by FACS-seq","volume":"10","author":"Noderer","year":"2014","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jbc.2024.107560_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature11058","article-title":"Sustained translational repression by eIF2\u03b1-P mediates prion neurodegeneration","volume":"485","author":"Moreno","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107560_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107560_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13073-022-01087-x","article-title":"A\u00a0systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project","volume":"14","author":"Blakes","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.jbc.2024.107560_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A\u00a0rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy","year":"1998","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2024.107560_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1261877","article-title":"Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome","volume":"348","author":"Rivas","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107560_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/15476286.2019.1674595","article-title":"Divergent effects of translation termination factor eRF3A and nonsense-mediated mRNA decay factor UPF1 on the expression of uORF carrying mRNAs and ribosome protein genes","volume":"17","author":"Aliouat","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.jbc.2024.107560_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41576-022-00556-8","article-title":"Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects","volume":"24","author":"Rogalska","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2024.107560_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Childs-Disney","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.107560_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev-pharmtox-010919-023738","article-title":"Antisense drugs Make Sense for Neurological diseases","volume":"61","author":"Bennett","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2024.107560_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In\u00a0vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107560_bib39","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","article-title":"Efficient in\u00a0vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jbc.2024.107560_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/nar\/gkaa1235","article-title":"The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration","volume":"49","author":"Jafar-Nejad","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107560_bib41","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1074\/jbc.RA120.014905","article-title":"Multimodal small-molecule screening for human prion protein binders","volume":"295","author":"Reidenbach","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107560_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","article-title":"Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein","volume":"356","author":"B\u00fceler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107560_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2024.107560_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1297-9716-43-87","article-title":"Healthy goats naturally devoid of prion protein","volume":"43","author":"Benestad","year":"2012","journal-title":"Vet. Res."},{"key":"10.1016\/j.jbc.2024.107560_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nbt1271","article-title":"Production of cattle lacking prion protein","volume":"25","author":"Richt","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2024.107560_bib46","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2024.107560_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2267-z","article-title":"Evaluating drug targets through human loss-of-function genetic variation","volume":"581","author":"Minikel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107560_bib48","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.jbc.2024.107560_bib49","doi-asserted-by":"crossref","first-page":"e3872","DOI":"10.1371\/journal.pone.0003872","article-title":"The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes","volume":"3","author":"Polymenidou","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107560_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T23:20:48Z","timestamp":1728084048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824020611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0021925824020611"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107560","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.19.572439","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of prion protein expression through cryptic splice site manipulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107560"}}